1. Rhabdomyolysis in Ebola Virus Disease. Results of an Observational Study in a Treatment Center in Guinea
- Author
-
Benoit Quentin, Hervé Granier, Thierry de Greslan, Philippe Dubrous, Ludovic Karkowski, M. Aletti, Vincent Foissaud, Nancy Maugey, Christophe Rapp, Magali Billhot, Nicolas Gagnon, Thierry Carmoi, Jean Marie Cournac, Christine Mac Nab, Audrey Mérens, Hélène Savini, Emmanuel Sagui, Helene Broto, Claire Rousseau, Pierre-Yves Cordier, Sophie Moroge, S. Duron, Jean Cotte, Gilles Cellarier, Julien Bordes, and Frédéric Janvier
- Subjects
Adult ,Male ,0301 basic medicine ,Microbiology (medical) ,myalgia ,medicine.medical_specialty ,030106 microbiology ,Disease ,medicine.disease_cause ,Rhabdomyolysis ,Young Adult ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Internal medicine ,medicine ,Humans ,Renal Insufficiency ,030212 general & internal medicine ,Young adult ,Creatine Kinase ,Creatinine ,Ebola virus ,biology ,business.industry ,Myalgia ,Hemorrhagic Fever, Ebola ,medicine.disease ,Surgery ,Infectious Diseases ,chemistry ,biology.protein ,Female ,Guinea ,Creatine kinase ,medicine.symptom ,business ,Viral load - Abstract
BACKGROUND The pathogenesis of Ebola virus disease (EVD) remains unclear. The sporadic nature of Ebola outbreaks and their occurrence in resource-limited settings have precluded the acquisition of extensive clinical and laboratory data. Rhabdomyolysis during EVD has been suggested to occur in previous studies showing increased aspartate aminotransferase-alanine aminotransferase ratios, but, to date, has not been confirmed with creatine kinase (CK) assays. METHODS We performed an observational study of 38 patients admitted to an Ebola treatment center from January to April 2015. CK values from patients with confirmed EVD were compared with those in patients without confirmed EVD. A panel of other analyses were also performed. In patients with EVD, characteristics were compared between survivors and nonsurvivors. RESULTS High levels of CK were more frequent in patients with EVD than in those without (P = .002), and rhabdomyolysis was more frequent (59% vs 19%, respectively; P = .03). CK levels >5000 U/L were observed in 36% of patients with EVD. Also in patients with EVD, fatal outcome was significantly associated with higher creatinine and bilirubin levels, international normalized ratio, and viral load. CONCLUSIONS Rhabdomyolysis is a frequent disorder in EVD and seems to be more common than in other viral infections. It may contribute to the renal failure observed in nonsurviving patients. More studies are needed to determine the impact of rhabdomyolysis on EVD outcome.
- Published
- 2015